SEC Filings - Better Therapeutics, Inc

Filing date	Form	Description	Filing Group	View
May 18, 2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0000950170-23-022874.pdf 0000950170-23-022874.rtf 0000950170-23-022874.xls View HTML
May 11, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0000950170-23-020845.pdf 0000950170-23-020845.rtf 0000950170-23-020845.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
May 11, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	0000950170-23-020848.pdf 0000950170-23-020848.rtf 0000950170-23-020848.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
May 11, 2023	424B5	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	Registration Statements	0001193125-23-142186.pdf 0001193125-23-142186.rtf View HTML
May 11, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001193125-23-142195.pdf 0001193125-23-142195.rtf 0001193125-23-142195.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Apr 25, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	0000950170-23-014415.pdf 0000950170-23-014415.rtf 0000950170-23-014415.xls View HTML
Apr 25, 2023	ARS	An annual report to security holders	Annual Filings	0000950170-23-014430.pdf 0000950170-23-014430.rtf View HTML
Apr 25, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	0000950170-23-014418.pdf 0000950170-23-014418.rtf 0000950170-23-014418.xls View HTML
Apr 25, 2023	EFFECT	EFFECT	Other	9999999995-23-001045.pdf 9999999995-23-001045.rtf 9999999995-23-001045.xls View HTML
Apr 25, 2023	EFFECT	EFFECT	Other	9999999995-23-001046.pdf 9999999995-23-001046.rtf 9999999995-23-001046.xls View HTML

Data provided by Kaleidoscope.